Episurf Medical Future Growth
Future criteria checks 2/6
Episurf Medical is forecast to grow earnings and revenue by 8.4% and 93.5% per annum respectively. EPS is expected to decline by 28.7% per annum. Return on equity is forecast to be -73% in 3 years.
Key information
8.4%
Earnings growth rate
-28.7%
EPS growth rate
| Medical Equipment earnings growth | 36.6% |
| Revenue growth rate | 93.5% |
| Future return on equity | -73.0% |
| Analyst coverage | Low |
| Last updated | 28 Oct 2024 |
Recent future growth updates
Recent updates
Shareholders May Be More Conservative With Episurf Medical AB (publ)'s (STO:EPIS B) CEO Compensation For Now
Apr 03
Here's Why Episurf Medical (STO:EPIS B) Must Use Its Cash Wisely
Feb 27Is Episurf Medical (STO:EPIS B) In A Good Position To Invest In Growth?
Nov 09Will Episurf Medical (STO:EPIS B) Spend Its Cash Wisely?
May 03We're Not Very Worried About Episurf Medical's (STO:EPIS B) Cash Burn Rate
Sep 23Episurf Medical (STO:EPIS B) Is In A Good Position To Deliver On Growth Plans
Oct 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 523 | -65 | -65 | -60 | 1 |
| 12/31/2025 | 208 | -68 | -65 | -62 | 1 |
| 12/31/2024 | 132 | -74 | -74 | -68 | 1 |
| 9/30/2024 | 13 | -80 | -85 | -79 | N/A |
| 6/30/2024 | 12 | -85 | -92 | -84 | N/A |
| 3/31/2024 | 11 | -92 | -93 | -85 | N/A |
| 12/31/2023 | 10 | -95 | -94 | -85 | N/A |
| 9/30/2023 | 1 | -97 | -96 | -85 | N/A |
| 6/30/2023 | 2 | -94 | -88 | -77 | N/A |
| 3/31/2023 | 5 | -84 | -85 | -74 | N/A |
| 12/31/2022 | 7 | -77 | -81 | -69 | N/A |
| 9/30/2022 | 14 | -72 | -74 | -63 | N/A |
| 6/30/2022 | 12 | -71 | -72 | -62 | N/A |
| 3/31/2022 | 9 | -69 | -70 | -61 | N/A |
| 12/31/2021 | 7 | -69 | -67 | -60 | N/A |
| 9/30/2021 | 7 | -67 | -63 | -58 | N/A |
| 6/30/2021 | 7 | -66 | -61 | -56 | N/A |
| 3/31/2021 | 5 | -63 | -60 | -55 | N/A |
| 12/31/2020 | 5 | -64 | -59 | -54 | N/A |
| 9/30/2020 | 5 | -66 | -63 | -58 | N/A |
| 6/30/2020 | 5 | -69 | -63 | -59 | N/A |
| 3/31/2020 | 5 | -73 | -66 | -61 | N/A |
| 12/31/2019 | 5 | -70 | -65 | -59 | N/A |
| 9/30/2019 | 5 | -66 | -62 | -55 | N/A |
| 6/30/2019 | 5 | -62 | -69 | -61 | N/A |
| 3/31/2019 | 4 | -59 | -62 | -54 | N/A |
| 12/31/2018 | 4 | -58 | -62 | -52 | N/A |
| 9/30/2018 | 4 | -58 | -64 | -55 | N/A |
| 6/30/2018 | 3 | -59 | N/A | -49 | N/A |
| 3/31/2018 | 3 | -55 | N/A | -62 | N/A |
| 12/31/2017 | 3 | -61 | N/A | -61 | N/A |
| 9/30/2017 | 3 | -64 | N/A | -59 | N/A |
| 6/30/2017 | 2 | -65 | N/A | -59 | N/A |
| 3/31/2017 | 2 | -69 | N/A | -53 | N/A |
| 12/31/2016 | 2 | -62 | N/A | -56 | N/A |
| 9/30/2016 | 7 | -57 | N/A | -55 | N/A |
| 6/30/2016 | 8 | -53 | N/A | -50 | N/A |
| 3/31/2016 | 7 | -48 | N/A | -44 | N/A |
| 12/31/2015 | 7 | -44 | N/A | -38 | N/A |
| 9/30/2015 | 2 | -38 | N/A | -34 | N/A |
| 6/30/2015 | 2 | -34 | N/A | -34 | N/A |
| 3/31/2015 | 2 | -32 | N/A | -30 | N/A |
| 12/31/2014 | 2 | -33 | N/A | -32 | N/A |
| 9/30/2014 | 3 | -31 | N/A | -31 | N/A |
| 6/30/2014 | 2 | -28 | N/A | -31 | N/A |
| 3/31/2014 | 2 | -26 | N/A | -25 | N/A |
| 12/31/2013 | 2 | -23 | N/A | -21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EPIS B is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EPIS B is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EPIS B is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EPIS B's revenue (93.5% per year) is forecast to grow faster than the Swedish market (-0.03% per year).
High Growth Revenue: EPIS B's revenue (93.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EPIS B is forecast to be unprofitable in 3 years.